Genetic editing technologies like CRISPR raise ethical questions about the potential to prevent diseases in unborn children.

We are at a pivotal point where technology can change who we are genetically, and we need to understand what it means to be human before we give that away.

Nanotechnology, particularly DNA manipulation, shows promise in curing diseases and enhancing health.

The model can interpret genetic mutations and provide insights into their functional consequences, which is state-of-the-art in computational biology.

There's a significant opportunity in generating in vivo data, which is currently limited, to better understand drug interactions in real biological systems, and we're seeing breakthroughs in data-generating technology in biology and chemistry that will significantly impact how we model these fields.

We are on the brink of a new generation of technology that has the potential to enhance our capabilities and make us better versions of ourselves.

We aim to create technologies and platform capabilities that are broadly useful, enabling new mechanistic insights and potentially curing diseases.

Editing gene expression rather than the genetic code itself may face fewer regulatory barriers, as it involves transient changes rather than permanent alterations to DNA.

The future may involve programming proteins as a new form of technology, bridging the gap between computers and human health, which is currently underexploited. With advancements in machine learning, like AlphaFold, we can now predict how DNA sequences fold into proteins in just minutes, potentially revolutionizing how we build machines that interact with the human body and our environment.